APA (7th ed.) Citation

Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, . . . Wang JH. (2021). Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]. Dove Medical Press.

Chicago Style (17th ed.) Citation

Cheng SL, et al. Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in Patients Without Optimally Controlled Asthma (REACT) Study [Corrigendum]. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Cheng SL, et al. Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in Patients Without Optimally Controlled Asthma (REACT) Study [Corrigendum]. Dove Medical Press, 2021.